Kentucky BioProcessing LLC (KBP) has been awarded a patent for a veterinary vaccine produced with tobacco plants. KBP’s parvovirus vaccine, which has potential for both feline and canine applications, builds on the company’s already-patented Geneware technology, a plant-based gene expression systems that uses a specifically altered tobacco mosaic virus as a vehicle to carry a target protein. Once the altered virus is introduced into a host plant, the natural growth of the plant causes the protein to be reproduced in larger quantities.
-
Share This!
Owensboro
October 1, 2008
342 Views
You may also like
Popular Stories
Lane One-On-One: Exports Drive Kentucky Bourbon Boom
April 15, 2024
SRC of Lexington investing $15M to expand
April 15, 2024
The Lane Report
- Hard Truth Distilling, Co. Begins Construction of the Third Rackhouse
- Workforce-optimizer Red e App rebrands to Workrede
- UK updates research guidelines for use of AI
- The Innovation That Revived Bourbon
- 2nd Release of our Wildlife Collection, 2024 Mockingbird
- Big Ass Fans releases salt-, sand-resistant Haiku Coastal model
- GE Appliances introduces Spanish-language washer for U.S.
- Leadership Lexington taking applications through May 15
- 21 join fourth cohort of GLI’s minority business accelerator
- UK Global Health breaks ground on new Ecuador clinic
Add Comment